{
  "paper_metadata": {
    "pmid": "27652282",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on the TTR V122I variant, including penetrance data and individual records."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.424G>A",
      "protein_notation": "p.Val142Ile",
      "genomic_position": "rs76992529",
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 2767,
        "demographics": "Various African populations",
        "phenotype": "Cardiac amyloidosis in elderly carriers"
      },
      "penetrance_data": {
        "total_carriers_observed": 2767,
        "affected_count": null,
        "unaffected_count": null,
        "uncertain_count": null,
        "penetrance_percentage": null,
        "age_dependent_penetrance": [
          {
            "age_range": "70 years and older",
            "penetrance_percentage": null,
            "carriers_in_range": null,
            "affected_in_range": null
          }
        ]
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": null,
          "age_at_onset": null,
          "age_at_diagnosis": null,
          "sex": null,
          "affected_status": "uncertain",
          "phenotype_details": "Clinical impact likely occurs in the seventh decade of life or later.",
          "evidence_sentence": "It appears that in the heterozygous state the allele is clinically silent until the seventh decade of life or later."
        }
      ],
      "functional_data": {
        "summary": "The TTR V122I variant is associated with decreased stability of the TTR tetramer, leading to amyloid deposition.",
        "assays": [
          "PCR-based assays",
          "DNA sequencing"
        ]
      },
      "segregation_data": "The allele is clinically silent until late in life, suggesting it may not segregate with disease in younger individuals.",
      "population_frequency": "0.0253 in high-prevalence West African countries; 0.0173 in African Americans.",
      "evidence_level": "Strong evidence based on population studies and clinical associations.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The allele frequency is significantly higher in West Africa compared to other regions.",
      "key_quotes": [
        "The allele represents a significant risk for congestive heart failure late in life.",
        "The allele does not influence survival to adulthood and is unlikely to be under positive or negative selective evolutionary pressure."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "All relevant data regarding the TTR V122I variant was extracted from the main text."
  }
}